Clinical Trial Update: Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on four weeks of oral D. Piger in overweight individuals to assess safety, pharmacokinetics, and ethanol metabolism; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Steatosis
• Metabolic Syndrome
• Obesity

Drugs mentioned

• D. Piger

Snippet

Sponsor: Max Nieuwdorp | Conditions: Obesity, Metabolic Syndrome | Phase 1 | Status: RECRUITING